Fundamental Data for LJPC

LA JOLLA P(NSDQ:LJPC)

LA JOLLA PHARMACEUTICAL CO. is engaged in the research and development of therapeutic products for the treatment of autoimmune and inflammatory diseases.

# Employees: 86

Address: 6455 Nancy Ridge Drive,San Diego,CA,USA

Phone: 858 452-6600

Fax: 858-452-6893

Website: www.ljpc.com

Email: info@amstock.com

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Deirdre Y. Gillespie M.D. (Presi.; C.E.O.; Asst. Sec.)

Gail A. Sloan (V.P. Fin.; Sec.; Princ. Acctg. Off.)

Niv E. Caviar (Exec. V.P.; C.F.O.; Chief Bussiness Off.)

Thomas A. Adams Ph.D. (Dir.)

Stephen M. Martin (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2008

Next Earnings Date(Expected): 11/17/2009

Mean EPS (Next Qtr): ($0.01)

Mean EPS (Year): ($0.01)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 0

Shares Performance

Period	LJPC	Compare to S&P
YTD	-88.45 %	-90.44 %
4 Weeks	-15.19 %	-16.10 %
12 Weeks	-69.54 %	-71.29 %

Shares Information

Analyst Coverage: N

Avg Volume: 2306412

Shares Outstanding: 65M

Market Cap: $0.00B

52 Week High: $2.79

52 Week Low: $0.04

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 12/22/2005 LJPC split by factor of 0.200

Earnings Performance

EPS Growth in Last Quarter: 62.50 %

EPS Growth in Last Year: 90.32 %

Sales Growth in Last Quarter: -0.01 %

Financials

Qtr Book Value: $0.74

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: -0.010